NCT00670696

A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel

A Randomised, Controlled, Single-blinded, Cross Over Comparison Study to Compare the Efficacy of the Rapydan Medicated Plaster Versus Tetracaine Gel

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Jazz Pharmaceuticals · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Tetracaine gel 4% is a topical anaesthetic gel commonly used in the UK that contains 40 mg of tetracaine base per gram. Adequate anaesthesia can usually be achieved following a 30 minute application time for venopuncture and a 45 minute application time for venous cannulation. The hypothesis is that Rapydan medicated plaster is more effective than tetracaine gel in preventing venous cannulation related pain when applied for the recommended treatment durations of 30 minutes and 45 minutes respectively.

Detailed description

Tetracaine gel 4% is a topical anaesthetic gel commonly used in the UK that contains 40 mg of tetracaine base per gram. Adequate anaesthesia can usually be achieved following a 30 minute application time for venopuncture and a 45 minute application time for venous cannulation. The hypothesis is that Rapydan medicated plaster is more effective than tetracaine gel in preventing venous cannulation related pain when applied for the recommended treatment durations of 30 minutes and 45 minutes respectively. This study has been withdrawn and no additional data is available.

Conditions

• Healthy
• Anesthesia

Interventions

Type	Name	Description
DRUG	Rapydan	Topical anaesthetic plaster
DRUG	tetracaine gel	Topical tetracaine gel

Timeline

• Start date: 2008-04-01
• Primary completion: 2008-12-01
• First posted: 2008-05-02
• Last updated: 2012-04-25

Locations

1 site across 1 country: United Kingdom